REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 630 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Other Real Estate Property | Office Administrative Services
Full name: Dr.Max 630 S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 630 S.R.O. is based in Slovakia. The head office is in Kosice. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on August 08, 2013. In its most recent financial highlights, the company reported a net sales revenue increase of 21.56% in 2024. A growth of 25.02% was recorded in its total assets. In, 2024, the company’s net profit margin increased by 0.35%.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 630 S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Dr.Max 630 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 630 S.R.O. report to view the information.
Incorporation Date:
August 08, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 630 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
21.56%
Total operating revenue
21.6%
Operating profit (EBIT)
62.6%
EBITDA
39.35%
Net Profit (Loss) for the Period
46.99%
Total Assets
25.02%
Total Equity
20.73%
Operating Profit Margin (ROS)
0.61%
Net Profit Margin
0.35%
Return on Equity (ROE)
3.07%
Debt/Equity
-0.65%
Quick Ratio
0.1%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?